Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
about
A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulationPharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport.Asthma medication is increasingly prescribed for finnish olympic athletes--for a reason?
P2860
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Overcoming beta-agonist tolera ...... o randomised controlled trials
@ast
Overcoming beta-agonist tolera ...... o randomised controlled trials
@en
type
label
Overcoming beta-agonist tolera ...... o randomised controlled trials
@ast
Overcoming beta-agonist tolera ...... o randomised controlled trials
@en
prefLabel
Overcoming beta-agonist tolera ...... o randomised controlled trials
@ast
Overcoming beta-agonist tolera ...... o randomised controlled trials
@en
P2860
P356
P1433
P1476
Overcoming beta-agonist tolera ...... o randomised controlled trials
@en
P2093
Robert J Hancox
Sarah Haney
P2860
P2888
P356
10.1186/1465-9921-8-19
P577
2007-03-06T00:00:00Z
P5875
P6179
1030743645